(Q44635621)

4 December 2017

A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial (English)

1 reference

4 December 2017

A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300327

26 March 2024

1 reference

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300327

26 March 2024

5

Jeffrey A Lieberman

1 reference

4 December 2017

Linmarie Sikich

1

1 reference

4 December 2017

Robert M. Hamer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583740

26 March 2024

Robert A. Bashford

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583740

26 March 2024

Brian B. Sheitman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583740

26 March 2024

Jeffrey A. Lieberman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583740

26 March 2024

language of work or name

English

0 references

publication date

1 January 2004

1 reference

full work available at URL

4 December 2017

https://www.nature.com/articles/1300327.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583740

http://www.nature.com/articles/1300327.pdf

26 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300327

http://www.nature.com/articles/1300327

26 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300327

26 March 2024

published in

Neuropsychopharmacology

1 reference

4 December 2017

29

1 reference

4 December 2017

1

1 reference

4 December 2017

133-145

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300327

4 December 2017

0 references

cites work

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Medication treatment in subjects with autistic spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

A double-blind pilot study of risperidone in the treatment of conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

A revised anchored version of the BPRS-C for childhood psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Adjunctive antipsychotic treatment of adolescents with bipolar psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Olanzapine versus haloperidol in children with autistic disorder: an open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Risperidone-associated weight gain in children and adolescents: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Symptom factors in early-onset psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Risperidone in children with autism and serious behavioral problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Looking for childhood-onset schizophrenia: the first 71 cases screened

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Atypical neuroleptics in child and adolescent psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Diabetic ketoacidosis associated with olanzapine in an adolescent patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Children with schizophrenia: diagnosis, phenomenology, and pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Elevated prolactin in pediatric patients on typical and atypical antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

Adjunctive antipsychotic treatment is necessary for adolescents with psychotic mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

7 January 2021

Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

7 January 2021

The diagnosis and treatment of children and adolescents with schizophrenia. "My mind is playing tricks on me".

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

7 January 2021

Novel antipsychotic medications in the treatment of children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

7 January 2021

Use of atypical neuroleptics in child and adolescent psychiatry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

7 January 2021

Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

7 January 2021

Novel antipsychotics and new onset diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300327

7 January 2021

Hospital & community psychiatry

27

39

1172

MR Munetz

1988

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300327

A rating scale for extrapyramidal side effects

26 March 2024

38

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300327

26 March 2024

Identifiers

1 reference

4 December 2017

1 reference